ClinicalTrialsFinder

Soft Tissue Sarcoma (STS) Clinical Trials in Seoul, Seoul

1 recruitingSeoul, Seoul, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+3 more
GI Innovation, Inc.358 enrolled11 locationsNCT05824975